Noradrenergic and cholinergic systems are among the most vulnerable brain systems in
neuropsychiatric diseases of ageing, including Alzheimer's disease, Parkinson's disease …

Neural degeneration is a hallmark of healthy aging and can be associated with specific
cognitive impairments. However, neural degeneration per se is not matched by unremitting …

Problematic gambling has been suggested to be a possible consequence of dopaminergic
medications used mainly in neurological conditions, ie pramipexole and ropinirole, and …

Parkinson's disease (PD) and progressive supranuclear palsy (PSP) both impair response
inhibition, exacerbating impulsivity. Inhibitory control deficits vary across individuals and are …

Many people with Tourette syndrome are able to volitionally suppress tics, under certain
circumstances. To understand better the neural mechanisms that underlie this ability, we …

Studies have shown that alertness can affect inhibitory control, the mechanism responsible
for stopping behaviors, thoughts, or emotions. Inhibitory control is particularly important for …

An unknown impurity was identified using the HPLC technique at relative retention time~
1.07 with a peak area of 0.45% during the commercial synthesis of atomoxetine. The profile …

El propósito de esta revisión sistemática es explorar el papel de las monoaminas en la
inhibición prepulso (IPP) como un posible biomarcador para el diagnóstico, la progresión y …

Gait is a complex and dynamic phenomenon based on efficient and functional inter-
communication between diverse brain structures. It implies motor control mechanisms going …

arkinson's Disease is a debilitating neuro-degenerative disorder which has a major impact
on patients and their quality of life. The main pathological feature is the loss of dopaminergic …